Cargando…

1635 A Retrospective Study Comparing Outcomes of Present on Admission Clostridium difficile Infection (CDI) vs Non-present on Admission CDI at a Tertiary-care Hospital in Detroit

Detalles Bibliográficos
Autores principales:	Awali, Reda A., Singh, Iqbaljit, Narukonda, Sandhya, Gaddipati, Sruthi, Marwaha, Bharat, Kaye, Keith, Chopra, Teena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782160/ http://dx.doi.org/10.1093/ofid/ofu052.1181

Ejemplares similares

527 Age-Related Changes in the Incidence of Community-Associated Clostridium Difficile Infection (CDI)
por: Faden, Howard
Publicado: (2014)

973 Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients
por: Stevens, Vanessa, et al.
Publicado: (2014)

453 Association of Clostridium difficile Infection (CDI) with Excess Mortality after Liver Transplantation (LT) for Hilar Cholangiocarcinoma (CCA)
por: Ramanan, Poornima, et al.
Publicado: (2014)

1630 Excess Length of Stay Attributable to Clostridium difficile Infection (CDI) in the Acute Care Setting: A Multi-State Model
por: Stevens, Vanessa, et al.
Publicado: (2014)

1636 Low Incidence Of Clostridium Difficile Infection (CDI) in Patients Treated with Community Outpatient Parenteral Antimicrobial Therapy (CoPAT)
por: Wong, Ken Koon, et al.
Publicado: (2014)

1653 Results of a Treatment Protocol Encouraging First-Line Use of Fidaxomicin for Select Patients with Clostridium difficile Infection (CDI)
por: Navalkele, Bhagyashri, et al.
Publicado: (2014)

1627 Diagnostic Accuracy of Loop-Mediated Isothermal DNA Amplification (LAMP) Assay for Detection of Clostridium difficile Infection (CDI): a Meta-Analysis
por: Lloyd, Aaron, et al.
Publicado: (2014)

114 Case Mix Index Predicts Healthcare Facility Onset Clostridium difficile Infection (CDI) Reported to the National Healthcare Safety Network (NHSN)
por: Thompson, Nicola D., et al.
Publicado: (2014)

902 Hospital Characteristics and Infection Prevention and Control Strategies Associated with Methicillin-Resistant Staphylococcus aureus (MRSA) and Clostridium difficile Infection (CDI) in Canadian Hospitals
por: Williams, Victoria, et al.
Publicado: (2014)

115 Comparison of Emerging Infections Program (EIP) and National Healthcare Safety Network (NHSN) Datasets for Surveillance of Methicillin-Resistant Staphylococcus aureus (MRSA) and Clostridium difficile Infection (CDI)
por: Phipps, Erin C., et al.
Publicado: (2014)

1651 Role of Metronidazole vs Vancomycin as Initial Therapy in Hospitalized Patients with Mild to Moderate Clostridium difficile Infection (CDI) with NAP1 vs non-NAP1 Disease
por: Dubrovskaya, Yanina, et al.
Publicado: (2014)

900 Present or Absent on Admission: Impact of Change in National Healthcare Safety Network Surveillance Definitions
por: Farrell, Lauren, et al.
Publicado: (2014)

488. Epidemiology and Outcomes for Stenotrophomonas maltophilia Infections at a Tertiary Care Center in Detroit, MI
por: Oring, Justin, et al.
Publicado: (2019)

276 Molecular Epidemiology of MRSA and VRE Co-colonization among Hospitalized Adults in Detroit
por: Martin, Emily T., et al.
Publicado: (2014)

Are Patients with Prior Clostridium difficile Infection (CDI) a Potential Source of Transmission during Hospital Admissions?
por: Gonzalez-Orta, Melany, et al.
Publicado: (2017)

Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI
por: Finn, Elaine, et al.
Publicado: (2021)

529 Frequent Transmission of Clostridium Difficile by Asymptomatically Colonized Long-term Care Facility Residents during Hospital Admissions
por: Donskey, Curtis J., et al.
Publicado: (2014)

SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI
por: Sattar, Abdul, et al.
Publicado: (2015)

684. Characteristics of Patients with Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences
por: Guh, Alice, et al.
Publicado: (2023)

A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018
por: Viprey, Virginie F, et al.
Publicado: (2022)

Use of Electronic Data to Identify Risk Factors Associated with Clostridium difficile Infection (CDI) and to Develop CDI Risk Scores
por: Aukes, Laurie, et al.
Publicado: (2017)

Imported Disease Pressure and Bulk Antibiotic Use: Novel Predictors of Facility-Level C. Difficile Infection (CDI) Incidence in the United States Veterans Health Administration
por: Brown, Kevin, et al.
Publicado: (2015)

New advances in the treatment of Clostridium difficile infection (CDI)
por: Hedge, Dennis D, et al.
Publicado: (2008)

Bezlotoxumab (BEZ) for Prevention of Clostridium Difficile Infection (CDI) Recurrence (rCDI): Outcomes in Patients with Substantial Renal Impairment (SRI)
por: Golan, Yoav, et al.
Publicado: (2017)

Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
por: Louie, Thomas J., et al.
Publicado: (2012)

1211. Response to Fecal Microbiota Transplant (FMT) in Refractory Clostridioides difficile Infection (CDI) is Modest Compared to Recurrent CDI in Hospitalized Patients
por: Shin, Jae Hyun, et al.
Publicado: (2020)

Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI
por: Castro, Iván, et al.
Publicado: (2019)

331 Risk Factors for Vancomycin-resistant Enterococci and Carbapenemase-producing Carbapenem-resistant Enterobacteriaceae Colonization at admission to a Tertiary-care Center
por: Chow, Angela, et al.
Publicado: (2014)

763 Low Hospital Admission Rates Following Physician Office Infusion Center (POIC)-Based Outpatient Treatment with Intravenous Antibiotics (IVABs)
por: Alvarado, Fernando S., et al.
Publicado: (2014)

Clostridioides difficile infection (CDI) during the COVID-19 pandemic
por: Spigaglia, Patrizia
Publicado: (2022)

332 Collateral Benefit of Screening Patients for Methicillin-Resistant Staphylococcus aureus at Hospital Admission: Serendipitous Isolation of Patients with Other Multidrug-Resistant Organisms
por: Jones, Makoto, et al.
Publicado: (2014)

Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study
por: Zilberberg, Marya D, et al.
Publicado: (2014)

Bezlotoxumab (BEZ) for Prevention of Clostridium difficile Infection (CDI) Recurrence (rCDI): Distinguishing Relapse from Reinfection with Whole Genome Sequencing (WGS)
por: Dorr, Mary Beth, et al.
Publicado: (2017)

JBoss Weld CDI for Java platform
por: Finnegan, Ken
Publicado: (2013)

Focusing stewardship to help tackle CDI
Publicado: (2020)

Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI)
por: Kullar, Ravina, et al.
Publicado: (2020)

2365. Volatile Metabolite-Based Detection of Clostridium difficile Infection (CDI)
por: Aloum, Obadah, et al.
Publicado: (2019)

Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDI
por: Navalkele, Bhagyashri D., et al.
Publicado: (2016)

995 Comparing the Clinical Presentation of Viral Causes of Pediatric Acute Gastroenteritis
por: Halasa, Natasha, et al.
Publicado: (2014)

1133 Consequences of Late Presentation for HIV Care in Mexico, 2007-2013
por: Zamboni, Daniela De La Rosa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jvfh76pbl36gqprfvjp46otu25